European community FP7
Genekam Biotechnology AG has been selected for business mission trip to Tokyo, 26-30 May 2014 under EU GATEWAY TO JAPAN-Healthcare and Medical technologies.
Genekam Biotechnology AG is one of 40 companies selected across the European Union.
Genekam got one project for development of Nanoassays for
nanomedicine under program ZIM
from German Federal Ministry of Economics and Technology.
Genekam is to take part in European Community FP7 ...
ArabLab The Expo 2014
Visit us in Dubai, UAE from 17.03 to 20.03.2014
26. CHINA MED 2014
Visit us in Beijing / VR China 21.03. - 23.03.2014
Medica Düsseldorf 2014
Visit us on Medica 2014 in Düsseldorf from 12.11 to 15.11.2014
New Catalog 2014
Our new Catalog is now released, please download
Hard fact - is it a sign of quality and confidence in our product?
... in 2004 we had clients in 5 countries in whole year and
in 2009 we served 60 countries of the world? There is a surge of medical publications
where Genekam PCR Kits are being used. Is it not a sign of quality and
Real time PCR Kits for Influenza A and swine flu (H1N1) (click here to see more information)
In vitro immunisation of human b-lymphocytes and human monoclonal antibodies
Genekam Solutions for combating SARS viruses
Genekam-Barcode: Biotech for nature and endangered species
(A new DNA-Test to know the exact species of an animal)
cDNA synthesis service
cDNA synthesis service: Genekam offers you cDNA synthesis services
from isolated RNA. cDNA can be stored for longer time and it can be
used to do multiple analysis. cDNA can be made from RNA isolated from
blood, plasma, skin, tissue, organs etc. of human, animals, fishes,
birds, ticks etc and the parts of plants. To send you quotation, we need the following information:
- The kind of sample: isolated RNA or raw samples, where one has to isolate the RNA
- Number of samples
- Purpose of cDNA: detection tumour markers, real time PCR etc
- any other information e.g. kind of preservation etc.
After getting the project, we will send you the quotation.